Grant Pickering
Grant Pickering's purchase track record
Grant Pickering has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/29/2023 | LONA | $60K | +24.5% | -19.8% | +6.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
LeonaBio appears among health‑care stocks moving intraday. LeonaBio was listed among twelve health‑care stocks that showed notable price movement on Monday and again on Friday, according to Benzinga. The mentions suggest the stock experienced intraday volatility during those sessions. With the RSI currently low and the price near a recent support level, the recent activity aligns with a broader sector‑wide movement.
Transaction History
| PCVX | ▼ Sell | Tax Withholding | 17,056 | $1.0M | 9/8/2026 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 3,427 | $211K | 9/2/2026 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 2,862 | $174K | 8/31/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 622 | $35K | 7/27/2026 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 16,198 | $33K | 7/27/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 11,783 | $654K | 7/27/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 4,415 | $247K | 7/27/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 756 | $42K | 7/27/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 244 | $14K | 7/27/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 378 | $21K | 7/27/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 6,417 | $360K | 6/26/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 312 | $17K | 6/26/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 9,137 | $505K | 6/26/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 6,683 | $363K | 6/26/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 356 | $20K | 6/26/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 332 | $19K | 6/26/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 207 | $11K | 6/26/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 602 | $33K | 6/26/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 191 | $11K | 6/26/2026 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 225 | $403 | 6/18/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 22,236 | $1.2M | 6/18/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,000 | $53K | 6/18/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,000 | $53K | 6/18/2026 | View on chart |
| PCVX | ▼ Sell | Open Market | 225 | $12K | 6/18/2026 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 3,685 | $219K | 3/9/2026 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 2,531 | $157K | 3/2/2026 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 2,863 | $177K | 2/28/2026 | View on chart |
| PCVX | ▲ Buy | Grant | 105,110 | $0 | 2/26/2026 | View on chart |
| PCVX | ▼ Sell | Gift | 100,000 | $0 | 1/14/2026 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 7,356 | $238K | 9/8/2025 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 2,857 | $90K | 9/2/2025 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 4,563 | $144K | 9/2/2025 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 3,420 | $108K | 9/2/2025 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 15,781 | $84K | 4/4/2025 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 4,752 | $99K | 4/4/2025 | View on chart |
| PCVX | ▲ Buy | Grant | 57,938 | $0 | 3/27/2025 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 7,984 | $576K | 3/3/2025 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 2,013 | $147K | 2/28/2025 | View on chart |
| PCVX | ▼ Sell | Open Market | 961 | $88K | 12/9/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 222 | $21K | 12/9/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,029 | $95K | 12/9/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 154 | $14K | 12/9/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 11,349 | $1.0M | 12/2/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,409 | $131K | 12/2/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,242 | $211K | 12/2/2024 | View on chart |
| PCVX | ▼ Sell | Gift | 710 | $0 | 11/18/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 227 | $23K | 11/7/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 463 | $48K | 11/7/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 377 | $39K | 11/7/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 116 | $12K | 11/7/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 281 | $29K | 11/7/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 363 | $38K | 11/7/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 434 | $45K | 11/7/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 105 | $11K | 11/7/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 663 | $27 | 11/7/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 14,129 | $29K | 11/7/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 16,000 | $86K | 11/7/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 9,955 | $1.1M | 11/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 3,312 | $356K | 11/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,733 | $188K | 11/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 887 | $96K | 10/7/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 310 | $33K | 10/7/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,113 | $232K | 10/7/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 239 | $26K | 10/7/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 356 | $38K | 10/7/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 807 | $88K | 10/7/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,849 | $202K | 10/7/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 537 | $59K | 10/7/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 3,624 | $411K | 10/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 7,088 | $810K | 10/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 4,288 | $493K | 10/1/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 20,000 | $107K | 10/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 4,305 | $488K | 10/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 9,429 | $1.1M | 10/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 6,266 | $720K | 10/1/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 20,000 | $107K | 10/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 4,899 | $555K | 10/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 9,627 | $1.1M | 10/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 5,474 | $629K | 10/1/2024 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 13,669 | $1.5M | 9/3/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 15,000 | $30K | 8/23/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 6,686 | $526K | 8/23/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 8,314 | $659K | 8/23/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,308 | $103K | 8/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,308 | $103K | 8/1/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 15,000 | $30K | 7/23/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 5,718 | $479K | 7/23/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 9,282 | $785K | 7/23/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 674 | $51K | 7/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 634 | $49K | 7/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 751 | $57K | 7/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 557 | $43K | 7/1/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 15,000 | $30K | 6/24/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 10,341 | $780K | 6/24/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 4,471 | $341K | 6/24/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 188 | $14K | 6/24/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 705 | $50K | 6/3/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 486 | $35K | 6/3/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 117 | $9K | 6/3/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 757 | $54K | 6/3/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 327 | $24K | 6/3/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 224 | $16K | 6/3/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 15,000 | $30K | 5/23/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 6,211 | $428K | 5/23/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 8,789 | $614K | 5/23/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 72 | $5K | 5/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 680 | $42K | 5/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 582 | $36K | 5/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 46 | $3K | 5/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 728 | $45K | 5/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 508 | $31K | 5/1/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 15,000 | $27K | 4/23/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 15,000 | $929K | 4/23/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 984 | $65K | 4/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 324 | $22K | 4/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 890 | $59K | 4/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 415 | $28K | 4/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 3 | $204 | 4/1/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 15,000 | $27K | 3/25/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 13,450 | $899K | 3/25/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,550 | $105K | 3/25/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 65,000 | $132K | 3/11/2024 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 7,967 | $570K | 3/2/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 506 | $37K | 3/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 439 | $32K | 3/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 363 | $27K | 3/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 366 | $27K | 3/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 591 | $43K | 3/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 351 | $26K | 3/1/2024 | View on chart |
| PCVX | ▲ Buy | Grant | 45,000 | $0 | 2/29/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 30,000 | $54K | 2/26/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 30,000 | $2.4M | 2/26/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 15,000 | $27K | 2/23/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,356 | $177K | 2/23/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 6,980 | $530K | 2/23/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 5,545 | $427K | 2/23/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 119 | $9K | 2/23/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 119 | $9K | 2/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 491 | $36K | 2/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 443 | $33K | 2/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 255 | $19K | 2/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 134 | $10K | 2/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 655 | $48K | 2/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 238 | $18K | 2/1/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 281 | $21K | 2/1/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 30,000 | $54K | 1/29/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 30,000 | $2.0M | 1/29/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 3,000 | $120 | 1/23/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 12,000 | $21K | 1/23/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,938 | $186K | 1/23/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 10,023 | $641K | 1/23/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 2,039 | $132K | 1/23/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 127 | $8K | 1/2/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 594 | $38K | 1/2/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 587 | $38K | 1/2/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 97 | $6K | 1/2/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 568 | $36K | 1/2/2024 | View on chart |
| PCVX | ▼ Sell | Open Market | 643 | $41K | 1/2/2024 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 10,000 | $400 | 12/26/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 7,450 | $457K | 12/26/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 7,550 | $469K | 12/26/2023 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 9,900 | $20K | 12/22/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 468 | $24K | 12/1/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 841 | $44K | 12/1/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 757 | $39K | 12/1/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 552 | $29K | 12/1/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 11,221 | $549K | 11/24/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 3,779 | $187K | 11/24/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,306 | $62K | 11/1/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,306 | $62K | 11/1/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 3 | $144 | 11/1/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 3 | $144 | 11/1/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 11,236 | $528K | 10/23/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 3,764 | $178K | 10/23/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 442 | $23K | 10/2/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 641 | $32K | 10/2/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 385 | $20K | 10/2/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 283 | $15K | 10/2/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 646 | $32K | 10/2/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 221 | $11K | 10/2/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 15,000 | $787K | 9/25/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,309 | $69K | 9/25/2023 | View on chart |
| PCVX | ▼ Sell | Open Market | 1,309 | $69K | 9/25/2023 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 10,378 | $529K | 9/5/2023 | View on chart |
| LONA | ▲ Buy | Open Market | 15,000 | $37K | 3/30/2023 | View on chart |
| LONA | ▲ Buy | Open Market | 10,000 | $23K | 3/29/2023 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 3,099 | $129K | 3/2/2023 | View on chart |
| PCVX | ▲ Buy | Grant | 53,875 | $0 | 3/1/2023 | View on chart |
| PCVX | ▲ Buy | Option Exercise | 15,158 | $31K | 12/30/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 4,773 | $118K | 9/26/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 227 | $6K | 9/26/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 4,681 | $116K | 9/26/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 319 | $8K | 9/26/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 11,000 | $307K | 9/15/2022 | View on chart |
| PCVX | ▼ Sell | Tax Withholding | 8,910 | $235K | 9/2/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 14 | $392 | 8/26/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 4,985 | $137K | 8/26/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 15 | $420 | 8/26/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 4,986 | $137K | 8/26/2022 | View on chart |
| PCVX | ▼ Sell | Open Market | 10,392 | $265K | 8/15/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Vaxcyte VAX-31 clears Phase III OPUS-1 trial endpoints
Vaxcyte announced that its VAX-31 vaccine met all primary endpoints in the pivotal Phase III OPUS-1 trial. This positive data point positions the company for additional readouts expected in the first half of 2027. The stock is currently trading near its 52-week high, reflecting strong market interest in the clinical progress.
Vaxcyte VAX-31 clears Phase III OPUS-1 trial endpoints. Vaxcyte announced that its VAX-31 vaccine met all primary endpoints in the pivotal Phase III OPUS-1 trial. This positive data point positions the company for additional readouts expected in the first half of 2027. The stock is currently trading near its 52-week high, reflecting strong market interest in the clinical progress.